BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260426T065222EDT-08559gGu5L@132.216.98.100
DTSTAMP:20260426T105222Z
DESCRIPTION:91Ë¿¹ÏÊÓƵ’s Neurology Grand Rounds features weekly talks on a vari
 ety  of clinical and research topics by both local and guest speakers. The
 y are held weekly on Wednesday mornings.\n\nGrand Rounds: Immunotherapy an
 d Glioblastoma – The Odyssey Continues\n\nSpeaker: David A. Reardon\, M.D
 \n\nTo join this Zoom meeting\, please register in advance\n\nMicrosoft Te
 ams meeting\n	Join: https://teams.microsoft.com/meet/282369257851528?p=lFsI
 073E8w884fUbSi\n	Meeting ID: 282 369 257 851 528\n	Passcode: EZ9iR3Rd\n\nDav
 id A. Reardon\, MD currently is a Professor of Medicine at Harvard Medical
  School\, serves as Director of the Center for Neuro-Oncology at the Dana-
 Farber Cancer Institute where he is the inaugural recipient of the Alperin
  Family Chair in Neuro-Oncology .\n\nHe previously served as Clinical Dire
 ctor at the Center for Neuro-Oncology at Dana-Farber (12 years) and as the
  Associate Deputy Director of the Preston Robert Tisch Brain Tumor Center 
 at Duke University Medical Center (11 years). He completed his residency a
 t John Hopkins Hospital and his fellowship at the University of Michigan.
 \n\nDr. Reardon is an active researcher with special interests in the desi
 gn and implementation of clinical trials for neuro-oncology and the precli
 nical evaluation of promising therapeutics for central nervous system tumo
 rs. His work includes using innovative clinical therapeutic agents to impr
 ove outcome for patients with brain and spinal tumors\, with particular fo
 cus on immunotherapeutics. He has also led investigations of molecular-tar
 geting agents\, anti-angiogenic reagents\, cytotoxins and other biological
 ly-based therapies.\n\nDr. Reardon has published over 420 peer-reviewed ma
 nuscripts. He received the R. Wayne Rundles Award for Excellence in Cancer
  Research (Duke University\, 2007) as well as the Award for Excellence in 
 Adult Clinical Research by the Society for Neuro-Oncology in 2015 and 2016
  and the James D. Griffin\, MD Medical Oncology Team Science Award (DFCI\,
  2023). He has contributed to the training of 54 neuro-oncology fellows. H
 e also served as the tenth president of the Society for Neuro-Oncology.\n
 \n \n
DTSTART:20260511T120000Z
DTEND:20260511T131500Z
LOCATION:De Grandpré Communications Centre
SUMMARY:Grand Rounds: Immunotherapy and Glioblastoma – The Odyssey Continue
 s
URL:/ipn/channels/event/grand-rounds-immunotherapy-and
 -glioblastoma-odyssey-continues-372446
END:VEVENT
END:VCALENDAR